Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
60 Degrees Pharmaceuticals, Inc. - Common Stock (SXTP) Insider Trading Activity
Healthcare • Biotechnology • 3 employees
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.
Total Value
$18,500.00
Total Shares
16,626
Average Trade Value
$9,250.00
Most Active Insider
Miller Tyrone
Total Activity: $10,000
Largest Single Transaction
$10,000
by Miller Tyrone on Jan 17, 2025
30-Day Activity
1 Transaction
Volume: 11,626 shares
Value: $10,000
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
CFO
Officer
|
Jan 17, 2025 | 11,626 | $10,000 | 26,370 (+44.1%) | Grant | |
Director
|
Aug 27, 2024 | 5,000 | $8,500 | 41,078 (+12.2%) | Purchase |